Monoclonal antibodies for the treatment of osteoporosis.
about
The osteocyte as a therapeutic target in the treatment of osteoporosisA review of osteocyte function and the emerging importance of sclerostinDiversity of the antibody response to tetanus toxoid: comparison of hybridoma library to phage display libraryOsteoporosis in older persons: current pharmacotherapy and future directions.The therapeutic potential of anti-interleukin-20 monoclonal antibody.New Target Sites for Treatment of Osteoporosis.Low-Density Lipoprotein Receptor-Related Proteins in Skeletal Development and Disease.Role of sclerostin and dkk1 in bone remodeling in type 2 diabetic patients.
P2860
Q27009129-40BB0AA8-D846-49B1-80F6-ADC6D83550F8Q34264395-CEA020F0-D232-442D-A8C9-3862C52DDE27Q34276746-74ABAA88-9BBE-4472-8A33-2660AC1B7DB5Q38124052-9379F714-EFCA-4D46-A6C8-9A89068A4047Q38210876-0979D701-3DFD-4A27-B0E3-32941B88A381Q39151180-3AFE2D31-C369-4ABD-93FE-37E9C7A3B79BQ39374128-AD16E293-32D2-4637-BCDC-726F7EAEDCECQ47621636-1DE439D2-6839-4B47-899B-BAFD67AAC59F
P2860
Monoclonal antibodies for the treatment of osteoporosis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Monoclonal antibodies for the treatment of osteoporosis.
@en
type
label
Monoclonal antibodies for the treatment of osteoporosis.
@en
prefLabel
Monoclonal antibodies for the treatment of osteoporosis.
@en
P2860
P1476
Monoclonal antibodies for the treatment of osteoporosis.
@en
P2093
E Michael Lewiecki
P2860
P304
P356
10.1517/14712598.2012.740006
P407
P577
2012-12-19T00:00:00Z